REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 154 filers reported holding REATA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $62,028,283 | -28.0% | 608,359 | -35.8% | 0.01% | -27.8% |
| Q1 2023 | $86,107,604 | +451.4% | 947,070 | +130.4% | 0.02% | +500.0% |
| Q4 2022 | $15,615,827 | +89.8% | 411,051 | +25.6% | 0.00% | +50.0% |
| Q3 2022 | $8,226,000 | +29.8% | 327,323 | +57.0% | 0.00% | 0.0% |
| Q2 2022 | $6,337,000 | -61.7% | 208,500 | -58.7% | 0.00% | -33.3% |
| Q1 2022 | $16,541,000 | +23.5% | 504,900 | -0.6% | 0.00% | – |
| Q4 2021 | $13,396,000 | +41.7% | 508,000 | +440.4% | 0.00% | -100.0% |
| Q3 2021 | $9,457,000 | -16.4% | 93,996 | +17.5% | 0.00% | -50.0% |
| Q2 2021 | $11,317,000 | -53.5% | 79,965 | -67.2% | 0.00% | -50.0% |
| Q1 2021 | $24,327,000 | -44.7% | 243,998 | -31.5% | 0.00% | 0.0% |
| Q4 2020 | $44,030,000 | +92.3% | 356,182 | +51.6% | 0.00% | 0.0% |
| Q3 2020 | $22,895,000 | -42.7% | 235,021 | -8.2% | 0.00% | -60.0% |
| Q2 2020 | $39,956,000 | +1.7% | 256,088 | -5.9% | 0.01% | -16.7% |
| Q1 2020 | $39,293,000 | -25.8% | 272,226 | +5.2% | 0.01% | -20.0% |
| Q4 2019 | $52,922,000 | +198.6% | 258,878 | +17.3% | 0.02% | +150.0% |
| Q3 2019 | $17,721,000 | -42.9% | 220,713 | -32.9% | 0.01% | +100.0% |
| Q2 2019 | $31,016,000 | +99.0% | 328,736 | +80.2% | 0.00% | -57.1% |
| Q1 2019 | $15,589,000 | +284.3% | 182,400 | +152.3% | 0.01% | +250.0% |
| Q4 2018 | $4,056,000 | -69.3% | 72,300 | -55.3% | 0.00% | -60.0% |
| Q3 2018 | $13,212,000 | +354.2% | 161,600 | +94.2% | 0.01% | +400.0% |
| Q2 2018 | $2,909,000 | +356.7% | 83,200 | +167.5% | 0.00% | – |
| Q1 2018 | $637,000 | +146.9% | 31,100 | +241.8% | 0.00% | – |
| Q4 2017 | $258,000 | -31.4% | 9,100 | -24.8% | 0.00% | – |
| Q3 2017 | $376,000 | – | 12,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |